Cresco Labs (CRLBF) Operating Expenses (2020 - 2026)
Cresco Labs (CRLBF) posted Operating Expenses of $64.3 million for Q1 2026, down 59.54% on a QoQ basis from $158.9 million in Q4 2025, and down 1.18% year-over-year from $65.0 million in Q1 2025.
Cresco Labs (CRLBF) Operating Expenses (2020 - 2026) Analysis & Trends
Cresco Labs' Operating Expenses history runs 7 years deep, the most recent figure standing at $64.3 million for Q1 2026.
- Quarterly Operating Expenses fell 1.18% year-over-year to $64.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $351.8 million (up 35.74% YoY) and the FY2025 annual result came in at $352.6 million, up 37.09% from the prior year.
- Operating Expenses was $64.3 million for Q1 2026 at Cresco Labs, down from $158.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $231.2 million in Q4 2022 and bottomed at $61.5 million in Q3 2025.
- A 5-year average of $95.0 million and a median of $69.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses tumbled 71.98% — and 2025, when it surged 145.85%.
- Cresco Labs' Operating Expenses stood at $231.2 million in 2022, then slumped by 70.13% to $69.0 million in 2023, then declined by 6.41% to $64.6 million in 2024, then jumped by 145.85% to $158.9 million in 2025, then plunged by 59.54% to $64.3 million in 2026.
- Business Quant data shows CRLBF's Operating Expenses at $64.3 million in Q1 2026, $158.9 million in Q4 2025, and $61.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Cresco Labs | 247.68 Mn | 184.10 Mn | 75.45 Mn | 64.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64.28 Mn |
| Dec 31, 2025 | 158.87 Mn |
| Sep 30, 2025 | 61.53 Mn |
| Jun 30, 2025 | 67.12 Mn |
| Mar 31, 2025 | 65.04 Mn |
| Dec 31, 2024 | 64.62 Mn |
| Sep 30, 2024 | 67.10 Mn |
| Jun 30, 2024 | 62.40 Mn |
| Mar 31, 2024 | 63.05 Mn |
| Dec 31, 2023 | 69.05 Mn |
| Sep 30, 2023 | 201.40 Mn |
| Jun 30, 2023 | 97.45 Mn |
| Mar 31, 2023 | 82.29 Mn |
| Dec 31, 2022 | 231.18 Mn |
| Sep 30, 2022 | 82.87 Mn |
| Jun 30, 2022 | 90.15 Mn |
| Mar 31, 2022 | 87.11 Mn |
| Dec 31, 2021 | 94.47 Mn |
| Sep 30, 2021 | 295.79 Mn |
| Jun 30, 2021 | 86.11 Mn |